Shuang Zhao, MD

Shuang Zhao, MD

Shuang Zhao, MD | University of Wisconsin-Madison

Articles by Shuang Zhao, MD

PORTOS Validation in Phase 3 Trials: Gene Signature Predictor of Dose-Response to Prostate Radiation

Shuang Zhao, MDProstate Cancer | March 3, 2025

Dr. Zhao shares how PORTOS predicts radiation dose response in prostate cancer and how it can be integrated into practice.